Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Inventory Average: 2023-2025

Historic Inventory Average for Tg Therapeutics (TGTX) over the last 3 years, with Sep 2025 value amounting to $151.1 million.

  • Tg Therapeutics' Inventory Average rose 82.12% to $151.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $151.1 million, marking a year-over-year increase of 82.12%. This contributed to the annual value of $75.1 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Tg Therapeutics reported Inventory Average of $151.1 million as of Q3 2025, which was down 3.45% from $156.5 million recorded in Q2 2025.
  • Tg Therapeutics' Inventory Average's 5-year high stood at $156.5 million during Q2 2025, with a 5-year trough of $28.7 million in Q2 2023.
  • Over the past 3 years, Tg Therapeutics' median Inventory Average value was $81.2 million (recorded in 2024), while the average stood at $85.8 million.
  • Data for Tg Therapeutics' Inventory Average shows a peak YoY surged of 176.67% (in 2024) over the last 5 years.
  • Over the past 3 years, Tg Therapeutics' Inventory Average (Quarterly) stood at $36.7 million in 2023, then surged by 165.93% to $97.6 million in 2024, then surged by 82.12% to $151.1 million in 2025.
  • Its last three reported values are $151.1 million in Q3 2025, $156.5 million for Q2 2025, and $134.1 million during Q1 2025.